METHOCARBAMOL AND ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
When do Methocarbamol And Aspirin patents expire, and when can generic versions of Methocarbamol And Aspirin launch?
Methocarbamol And Aspirin is a drug marketed by Ivax Sub Teva Pharms, Mcneil, Par Pharm, and Stevens J. and is included in four NDAs.
The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for METHOCARBAMOL AND ASPIRIN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | METHOCARBAMOL AND ASPIRIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METHOCARBAMOL AND ASPIRIN
US Patents and Regulatory Information for METHOCARBAMOL AND ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Sub Teva Pharms | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 087211-001 | Dec 22, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Stevens J | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 081145-001 | Jan 31, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mcneil | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 089193-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Par Pharm | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 089657-001 | Nov 4, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
